GENEVIEVE SARMIENTO: Open Payments
NPI 1255058616 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$151 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $65 · 2025 $151
Food & beverage: $151
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $35 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Viatris Specialty LLC | 1 | $30 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $15 |
Products named: ULTOMIRIS, VERQUVO, YUPELRI, LifeVest, Kerendia, Rezzayo.
Industry payments across FL — which companies pay providers there.
